These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7097220)

  • 1. Effect of propranolol on mortality and morbidity after acute myocardial infarction.
    Abela GS; Mehta J; Conti CR
    J Fla Med Assoc; 1982 Jun; 69(6):453-7. PubMed ID: 7097220
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience.
    Hawkins CM; Richardson DW; Vokonas PS
    Circulation; 1983 Jun; 67(6 Pt 2):I94-7. PubMed ID: 6342843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are all beta-blockers equally effective in reducing mortality after acute myocardial infarction (AMI)?
    Dickerson LM; Carek PJ
    J Fam Pract; 2001 Aug; 50(8):652. PubMed ID: 11509153
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical observations on propranolol in acute myocardial infarction: hemodynamics and metabolism.
    Mueller HS
    Triangle; 1980; 19(1):27-33. PubMed ID: 7456117
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of oral propranolol, intravenous mannitol and oxygen inhalation on ST segment mapping in acute myocardial infarction.
    Das BK; Ohri VC; Parashar SK; Tewari SC; Sindhi JC; Chatterji JC
    Indian Heart J; 1983; 35(2):106-10. PubMed ID: 6409801
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-blockers and mortality after myocardial infarction.
    Peters RW
    Arch Intern Med; 1987 Jan; 147(1):33-4. PubMed ID: 3541823
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term prognosis for patients undergoing thrombolysis during the acute phase of myocardial infarction].
    Bosset AJ; Vogt P; Eeckhout E; van Melle G; Monnier P; Schaller MD; Stauffer JC; Kappenberger L; Goy JJ
    Ann Cardiol Angeiol (Paris); 1997; 46(5-6):303-10. PubMed ID: 9295890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of obzidan in patients with a history of myocardial infarct].
    Il'iash MG
    Vrach Delo; 1988 Mar; (3):47-9. PubMed ID: 3394297
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of acute myocardial infarction with betareceptor blocking agents. I. Hemodynamic effects of Propranolol in combination with digitalis (author's transl)].
    Oeff M; Lehmann HU; Witt E; Hochrein H
    Z Kardiol; 1981 Jun; 70(6):445-9. PubMed ID: 7257499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol in acute myocardial infarction. A multicentre trial.
    Lancet; 1966 Dec; 2(7479):1435-8. PubMed ID: 4163441
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous administration of propranolol in the acute period of myocardial infarct].
    Gratsianskiĭ NA; Karpov IuA; Evdokimov VV; Bunaeva VE
    Ter Arkh; 1980; 52(10):33-9. PubMed ID: 7444780
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of obsidan and labetalol on the course of myocardial infarction].
    Sirenko IuN; Mironova OV; Ivanova DK; Shkliar LV
    Vrach Delo; 1988 Jun; (6):20-3. PubMed ID: 3047990
    [No Abstract]   [Full Text] [Related]  

  • 13. Morbidity and mortality after myocardial infarction.
    Hakkila J
    Bibl Cardiol; 1976; (36):159-63. PubMed ID: 1029451
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical characteristics, hospital morbidity and mortality, and up to 1-year follow-up events of acute myocardial infarction patients: the first report from Iran.
    Ghadimi H; Bishehsari F; Allameh F; Bozorgi AH; Sodagari N; Karami N; Yaghoubi M; Emami S; Ghadimi F; Haerizadeh BF; Sanati A
    Coron Artery Dis; 2006 Nov; 17(7):585-91. PubMed ID: 17047441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality.
    Fonarow GC; Wright RS; Spencer FA; Fredrick PD; Dong W; Every N; French WJ;
    Am J Cardiol; 2005 Sep; 96(5):611-6. PubMed ID: 16125480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Propranolol (Inderal) in acute myocardial infarct].
    Nielsen BL; Jorgensen FS; Clausen J; Felsby M; Roin J; Strange B
    Ugeskr Laeger; 1967 May; 129(21):689-96. PubMed ID: 4877646
    [No Abstract]   [Full Text] [Related]  

  • 17. Mortality and morbidity of acute ST segment elevation myocardial infarction in the current era.
    Jose VJ; Gupta SN
    Indian Heart J; 2004; 56(3):210-4. PubMed ID: 15584562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of obsidan in different hemodynamic variants of acute myocardial infarction].
    Netiazhenko VZ; Parkhomenko AN
    Vrach Delo; 1986 Jan; (1):12-5. PubMed ID: 3953032
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of spironolactone on mortality in patients with severe left ventricular dysfunction after acute myocardial infarction].
    Ruta J; Ptaszyński P; Maciejewski M; Chizyński K; Goch JH
    Przegl Lek; 2006; 63(12):1249-51. PubMed ID: 17642132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation.
    Melchior T; Kober L; Madsen CR; Seibaek M; Jensen GV; Hildebrandt P; Torp-Pedersen C
    Eur Heart J; 1999 Jul; 20(13):973-8. PubMed ID: 10361050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.